Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Acute Leukemia

Studies at this site

• Expanded Access Program for Revumenib — NO_LONGER_AVAILABLE